Detection of CD4 1 T cells specific for tumor-associated antigens is critical to investigate the spontaneous tumor immunosurveillance and to monitor immunotherapy protocols in patients. We investigated the ability of HLA-DR*1101 multimers to detect CD4 1 T cells specific for three highly promiscuous MAGE-A3 derived peptides: (p39), MAGE-A3 281-295 (p57) and MAGE-A3 286-300 (p58). Tetramers stained specific CD4 1 T cells only when loaded with p39, although all peptides activated the specific T cells when presented by plasticbound HLA-DR*1101 monomers. This suggested that tetramer staining ability was determined by the mode rather than the affinity of peptide binding to HLA-DR*1101. We hypothesized that peptides should bear a single P1 anchor residue to bind all arms of the multimer in a homogeneous register to generate peptide-HLA-DR conformers with maximal avidity. Bioinformatics analysis indicated that p39 contained one putative P1 anchor residue, whereas the other two peptides contained multiple ones. Designing p57 and p58 analogues containing a single anchor residue generated HLA-DR*1101 tetramers that stained specific CD4 1 T cells. Producing HLA-DR*1101 monomers linked with the optimized MAGE-A3 analogues, but not with the original epitopes, further improved tetramer efficiency. Optimization of CD4 1 T-cell epitope-binding registers is thus critical to generate functional HLA-DR tetramers.Key words: Anchor residues . HLA-DR Ă 1101 . MAGE-A3 . MHC tetramers . Tumor antigens
Supporting Information available online
IntroductionAnimal studies have clearly shown the critical role for CD4 1 T cells in anti-tumor immune response; nevertheless, little is known as yet about spontaneous tumor-specific CD4 1 T-cell responses in patients [1,2]. This knowledge would be instrumental to the definition of the mechanisms underlying tumor immunosurveillance and, possibly, tumor escape, as well as for the correct design of optimal vaccination strategies.CD4 1 T-cell responses specific for tumor associated antigens (TAA) can be investigated at the single cell level by using soluble [3][4][5][6]. The identification of primary antigen-specific CD4 1 T cells by peptide-pulsed MHC class II tetramers seems, however, less straightforward than that of CD8 1 T cells by peptide-loaded MHC class I tetramers [7,8]. Several biological and structural characteristics of the CD4 1 T-cell response that differ from those displayed by the CD8 1 one seem to affect the capacity of MHC class II tetramers to optimally stain specific CD4 1 T cells ex vivo: (i) the lower frequency of peptide-specific CD4 1 T cells, (ii) their apparent lower affinity for the peptide-MHC class II complexes [9][10][11][12][13], and (iii) the requirement for an activation-induced TCR reorganization to bind with sufficient avidity cognate peptide-MHC class II tetramers [12,14,15].Furthermore, the open structure of the MHC class II molecules allows peptides as long as 20 aa to extend out of the binding groove at both ends [16][17][18]. It is thus possible that a peptide,...